However, whether this increase in PBX1, a stem cell reprogramming factor in ovarian cancer chemoresistance [39], is primarily responsible for the drug resistance of ovarian cancer cells to carboplatin (shown in Fig. 7) or requires the cooperation of other factor(s) remains to be elucidated. This evidence concerns the gene PBX1 and ovarian carcinoma.